Translating Evidence into Practice: Expert Insights on Personalised
Lipid Management and Early Ezetimibe–Statin Combination Therapy
A distinguished group of local experts, including Dr Alan Fong, Professor Emeritus Dato’ Dr Wan Azman bin Wan Ahmad, Dr Saiful bin Kassim, Datin Dr Ong Mei Lin, Dr Emily Tan Lay Koon, Dr Syama Prasad Menon, and Dr Gnanasegaran Xavier, shared perspectives on optimising lipid management in Malaysia. Drawing on collective clinical experience, this article highlights practical strategies to improve lipid control in high-risk patients, emphasises the clinical value of early ezetimibe-statin combination therapy, and reinforces the importance of personalising treatment to achieve low-density lipoprotein cholesterol (LDL-C) targets effectively.
